Hiroe Toba
-
- Cardiac Fibrosis and Remodeling 5
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 4
-
- Hormonal Regulation and Hypertension 6
- Aging top 10%
-
- Bone and Dental Protein Studies 8
-
- Advanced Glycation End Products research 6
-
- Erythropoietin and Anemia Treatment 5
-
- Cardiac Ischemia and Reperfusion 5
-
- Eicosanoids and Hypertension Pharmacology 4
- Co-authors
- Tetsuo NakataMiyuki KobaraMerry L. LindseyLisandra E. de Castro BrásRugmani Padmanabhan IyerKazuki NodaHiroaki MatsubaraCatalin F. Baicu
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Hiroe Toba
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Cardiology and Cardiovascular Medicine 490
- Nephrology 97
- Endocrinology, Diabetes and Metabolism 226
- Aging 22
- Cancer Research 141
Countries citing papers authored by Hiroe Toba
This map shows the geographic impact of Hiroe Toba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroe Toba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroe Toba more than expected).
Fields of papers citing papers by Hiroe Toba
This network shows the impact of papers produced by Hiroe Toba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroe Toba. The network helps show where Hiroe Toba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroe Toba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 3 | |
| 12 | 2015 | 27 | |
| 13 | 2014 | 137 | |
| 14 | 2012 | 11 | |
| 15 | 2012 | 23 | |
| 16 | 2011 | 24 | |
| 17 | 2011 | 15 | |
| 18 | 2008 | 78 | |
| 19 | 2006 | 34 | |
| 20 | 2005 | 61 |
About Hiroe Toba
Hiroe Toba is a scholar working on Aging, Clinical Biochemistry and Nephrology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Bone and Dental Protein Studies (8 papers), Hormonal Regulation and Hypertension (6 papers), Advanced Glycation End Products research (6 papers), Erythropoietin and Anemia Treatment (5 papers), Cardiac Fibrosis and Remodeling (5 papers), Cardiac Ischemia and Reperfusion (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (490 citations), Nephrology (97 citations) and Endocrinology, Diabetes and Metabolism (226 citations). Hiroe Toba has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tetsuo Nakata, Miyuki Kobara, Merry L. Lindsey, Lisandra E. de Castro Brás, Rugmani Padmanabhan Iyer, Kazuki Noda, Hiroaki Matsubara, Catalin F. Baicu, Michael R. Zile and Amy D. Bradshaw.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.